Monitor Mondays Podcasts
National Quality Forum (NQF) issued two new reports this week that provide guidance to advance health information technology, with the intent of making healthcare more effective and safer for all Americans. The agency’s first report identifies critical areas where measurement can effectively assess the quality and impact of telehealth services. In the second report, NQF assesses the current state of interoperability and its impact on quality processes and outcomes.
Opposition is growing to a number of proposals in the 2018 Outpatient Prospective Payment System (OPPS) proposed rule, according to comments by hospital organizations released Wednesday by the Centers for Medicare & Medicaid Services (CMS) and reported by RACmonitor on Thursday.
Announced in June by UnitedHealthcare (UHC), its new policy begs the question: “Are you adding the modifier correctly for UHC services for your qualified healthcare professional?”
Last week the U.S. Department of Justice announced a $465 million settlement with Mylan, Inc., makers of the trouble-prone EpiPen, to resolve claims that it violated the False Claims Act. The corresponding suit, brought by Mylan’s competitor, Sanofi-Aventis US LLC, alleged improper misclassification of the EpiPen as a generic drug to avoid paying rebates owed mainly to Medicaid.